2007•The FASEB JournalRequires access

Role of protein kinase C in superoxide production by the renal medullary thick ascending limb from normal and diabetic rats

Jing Yang, Pamela K. Carmines

Open publisher page 0 citations

Abstract

Accelerated O 2 ·− production by the medullary thick ascending limb (mTAL) occurs during type 1 diabetes (T1D), and T1D activates protein kinase C (PKC) in a variety of tissues. The purpose of this study was to test the hypothesis that T1D‐induced PKC activation contributes to O 2 ·− production in the mTAL and to determine which PKC isoform(s) are involved. O 2 ·− production (lucigenin chemiluminescence) by mTAL suspensions prepared from normal rats ( n =6) averaged 426±26 RLU/sec/mg protein in 5.5 mM glucose media. Incubation 30 min in either 1 μM Calphostin C (pan‐specific PKC inhibitor), 1 μM Gö6976 (PKC α & β inhibitor) or 10 μM Rottlerin (PKC δ inhibitor) significantly decreased O 2 ·− production to 11±3, 17±3 or 2±1 % of baseline, respectively. PKC inhibitors had similar effects in normal mTALs exposed to 20 mM glucose for 30 min. mTAL suspensions from rats with streptozotocin‐induced T1D (STZ rats, 3–4 wk after onset; n =6) were prepared and studied in 20 mM glucose to maintain the chronic in vivo condition of the donor rats. O 2 ·− production was 2668±553 RLU/sec/mg in STZ mTALs ( P <0.05 vs normal mTALs) and significantly decreased to 9±2, 12±3 or 2±1 % of baseline, respectively, upon treatment with Calphostin C, Gö6976, or Rottlerin. We conclude that PKC activity is required for O 2 ·− production by mTALs from normal and diabetic rats, and that multiple PKC isoforms (α and/or β, as well as δ) are involved in this process.

About this research paper

What this paper is about

Accelerated O 2 ·− production by the medullary thick ascending limb (mTAL) occurs during type 1 diabetes (T1D), and T1D activates protein kinase C (PKC) in a variety of tissues. The purpose of this study was to test the hypothesis that T1D‐induced PKC activation contributes to O 2 ·− production in the mTAL and to determine which PKC isoform(s) are involved. O 2 ·− production (lucigenin chemiluminescence) by mTAL suspensions prepared from normal rats ( n =6) averaged 426±26 RLU/sec/mg protein in 5.5 mM glucose media. Incubation 30 min in either 1 μM Calphostin C (pan‐specific PKC inhibitor), 1 μM Gö6976 (PKC α & β inhibitor) or 10 μM Rottlerin (PKC δ inhibitor) significantly decreased O 2 ·− production to 11±3, 17±3 or 2±1 % of baseline, respectively. PKC inhibitors had similar effects in normal mTALs exposed to 20 mM glucose for 30 min. mTAL suspensions from rats with streptozotocin‐induced T1D (STZ rats, 3–4 wk after onset; n =6) were prepared and studied in 20 mM glucose to maintain the chronic in vivo condition of the donor rats. O 2 ·− production was 2668±553 RLU/sec/mg in STZ mTALs ( P <0.05 vs normal mTALs) and significantly decreased to 9±2, 12±3 or 2±1 % of baseline, respectively, upon treatment with Calphostin C, Gö6976, or Rottlerin. We conclude that PKC activity is required for O 2 ·− production by mTALs from normal and diabetic rats, and that multiple PKC isoforms (α and/or β, as well as δ) are involved in this process.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Accelerated O 2 ·− production by the medullary thick ascending limb (mTAL) occurs during type 1 diabetes (T1D), and T1D activates protein kinase C (PKC) in a variety of tissues. The purpose of this study was to test the hypothesis that T1D‐induced PKC activation contributes to O 2 ·− production in the mTAL and to determine which PKC isoform(s) are involved. O 2 ·− production (lucigenin chemiluminescence) by mTAL suspensions prepared from normal rats ( n =6) averaged 426±26 RLU/sec/mg protein in 5.5 mM glucose media. Incubation 30 min in either 1 μM Calphostin C (pan‐specific PKC inhibitor), 1 μM Gö6976 (PKC α & β inhibitor) or 10 μM Rottlerin (PKC δ inhibitor) significantly decreased O 2 ·− production to 11±3, 17±3 or 2±1 % of baseline, respectively. PKC inhibitors had similar effects in normal mTALs exposed to 20 mM glucose for 30 min. mTAL suspensions from rats with streptozotocin‐induced T1D (STZ rats, 3–4 wk after onset; n =6) were prepared and studied in 20 mM glucose to maintain the chronic in vivo condition of the donor rats. O 2 ·− production was 2668±553 RLU/sec/mg in STZ mTALs ( P <0.05 vs normal mTALs) and significantly decreased to 9±2, 12±3 or 2±1 % of baseline, respectively, upon treatment with Calphostin C, Gö6976, or Rottlerin. We conclude that PKC activity is required for O 2 ·− production by mTALs from normal and diabetic rats, and that multiple PKC isoforms (α and/or β, as well as δ) are involved in this process.

Key concepts: Rottlerin, Protein kinase C, Calphostin C, Endocrinology, Internal medicine, Calphostin, Chemistry, Superoxide

Related papers

Back to paper searchBrowse research topicsOriginal source
Role of protein kinase C in superoxide production by the renal medullary thick ascending limb from normal and diabetic rats — Research Paper | ScholarLens